Cancer BiologybioRxivPreprint
Targeting de novo lipogenesis improves gemcitabine efficacy in pancreatic ductal adenocarcinoma
Sarah E. Hancock, Linda L. Garthwaite, Konstantina Harellis…·Nigel A. Turner
This study identifies de novo lipogenesis as a mechanism of gemcitabine resistance in PDAC and shows that targeting lipid synthesis enzymes enhances treatment efficacy.
1 citation